Compound Access
Psilocybin
Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research.
Country Access Report
The Democratic Republic of the Congo (and Republic of the Congo) maintains strict drug control laws based on international conventions, with no established framework for medical psychedelic access.
Compound-specific notes summarise what is realistically available through approved medical use, clinical research, exceptional access, or private care where the country report has verifiable information.
Compound Access
Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research.
Last updated 20 Feb 2026. Source links are drawn from citation annotations in the medical access and reimbursement guide.